WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005115445) ENZYMES FOR PHARMACEUTICAL USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/115445    International Application No.:    PCT/DK2005/000342
Publication Date: 08.12.2005 International Filing Date: 24.05.2005
IPC:
A61K 38/48 (2006.01), A61P 1/18 (2006.01), A61P 3/10 (2006.01), A61P 11/00 (2006.01), A61P 1/14 (2006.01)
Applicants: NOVOZYMES A/S [DK/DK]; Krogshøjvej 36, DK-2880 Bagsværd (DK) (For All Designated States Except US).
SVENDSEN, Allan [DK/DK]; (DK) (For US Only).
KAASGAARD, Svend [DK/DK]; (DK) (For US Only).
BORCH, Kim [DK/DK]; (DK) (For US Only).
FISCHER, Morten [DK/DK]; (DK) (For US Only).
PETTERSSON, Dan [SE/DK]; (DK) (For US Only).
GREGORY, Peter, Colin [GB/DE]; (DE) (For US Only)
Inventors: SVENDSEN, Allan; (DK).
KAASGAARD, Svend; (DK).
BORCH, Kim; (DK).
FISCHER, Morten; (DK).
PETTERSSON, Dan; (DK).
GREGORY, Peter, Colin; (DE)
Common
Representative:
NOVOZYMES A/S; Krogshøjvej 36, DK-2880 Bagsværd (DK)
Priority Data:
PA 2004 00810 24.05.2004 DK
PA 2005 00101 20.01.2005 DK
Title (EN) ENZYMES FOR PHARMACEUTICAL USE
(FR) ENZYMES A VOCATION PHARMACEUTIQUE
Abstract: front page image
(EN)The pharmaceutical use of proteases related to a protease derived from Nocardiopsis sp. NRRL 18262 (SEQ ID NO: 1), optionally in combination with a lipase and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II.
(FR)L'invention concerne l'utilisation pharmaceutique de protéases liées à une protéase dérivée de Nocardiopsis sp. (NRRL 18262) (SEQ ID NO: 1), éventuellement en combinaison avec une lipase et/ou une amylase. On trouve comme exemples d'utilisations médicales : traitement de troubles digestifs, d'insuffisance pancréatique exocrine, de pancréatite, de fibrose kystique, de diabète de type I et/ou de diabète de type II.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)